<DOC>
	<DOC>NCT00667966</DOC>
	<brief_summary>Assess efficacy of Vardenafil in patients with traumatic spinal cord injury</brief_summary>
	<brief_title>Assess Efficacy in Subjects With Traumatic Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Men between 18 and 64 years old with stable cord injury (more than 6 months) who had erectile dysfunction according to the National Institutes if Health (NIH) after their traumatic spinal cord injury Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within prior 6 month Nitrate therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Spinal cord injury</keyword>
	<keyword>Urodynamic</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Vardenafil</keyword>
</DOC>